ARTICLE | Company News
Il-Yang Pharmaceutical Company Ltd., Tap Pharmaceutical deal
September 12, 2005 7:00 AM UTC
Il-Yang granted Tap a license to develop and distribute ilaprazole worldwide, excluding South Korea and China. Il-Yang is eligible for $40-$50 million in milestones. The proton pump inhibitor is expec...